‘Things Change,’ So Follow Up With Your Oncologist, Expert Says

Opinion
Video

Patients with cancer should always let their clinical team know if they are experiencing any new symptoms or concerns.

It is imperative that patients with breast cancer or any other disease be proactive about their health and let health care providers know about any new symptoms or other changes because, “the initial evaluation is only good as that point in time,” Dr. Claudia DeYoung said in an interview with CURE®.

DeYoung is an internist who specializes in breast health and runs the Center for Breast Health and Breast Cancer Survivorship Program at the South Sacramento Kaiser Permanente Medical Center in California. She emphasized that breast cancer — and any other health condition, really — can change, so staying on top of follow-up appointments and having open communication with clinicians can have a major impact on outcomes.

MORE: Mother with Stage 4 Breast Cancer and Her Family 'Focus on the Living'

According to Meryl Uranga, a patient advocate from KidneyCAN, patients and their caregivers should establish upfront expectations with their health care teams about wanting to have open communication and be an active participant in their clinical decision making.

“I really recommend finding that right fit in terms of experience, in terms of specialty areas and in terms of the communication style that they’re willing to provide and work with you on,” Uranga told CURE® during a recent Speaking Out video series.

DeYoung even mentioned that she sometimes will “track down” her patients if they are overdue for an appointment with their team, “because morally and professionally, it’s the right thing to do,” she said.

Transcript

I think that (with) breast health, like any area of the body, it's important to be proactive, you know. I really try to have a rapport with my patients and educate them that they need to be aware of their own body. My exam, her initial impression, the initial evaluation, is only good at that point in time. And that's why I always tell all my patients, any new changes, any concerns, come back in. That's why I will track my patients down if they're overdue. Because morally and professionally, it's the right thing to do. And things change, things evolve. Hindsight is 20/20.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Image of a woman with short blonde hair wearing a white blazer.
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Image of a woman with black hair.
Image of a woman with brown shoulder-length hair in front of a gray background that says CURE.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE